Formidable Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,722	Closed	-$514K	–	335
2023 Q1	$514K	Sell	4,722 -1,900	-29%	-$210K	0.11%	175
2022 Q4	$754K	Buy	+6,622	New	+$550K	0.17%	113
2022 Q2	–	Sell	-8,678	Closed	-$913K	–	362
2022 Q1	$913K	Buy	+8,678	New	+$846K	0.18%	108
2021 Q4	–	Sell	-8,500	Closed	-$931K	–	365
2021 Q3	$931K	Sell	8,500 -290	-3%	-$30.1K	0.17%	109
2021 Q2	$822K	Sell	8,790 -75	-0.8%	-$6.9K	0.18%	111
2021 Q1	$802K	Buy	8,865 +230	+3%	+$19.4K	0.17%	118
2020 Q4	$626K	Buy	8,635 +775	+10%	+$57.6K	0.15%	130
2020 Q3	$627K	Sell	7,860 -40	-0.5%	-$2.75K	0.18%	110
2020 Q2	$450K	Sell	7,900 -1,100	-12%	-$47.1K	0.13%	148
2020 Q1	$267K	Buy	+9,000	New	+$304K	0.11%	149
2018 Q4	–	Sell	-12,725	Closed	-$241K	–	114
2018 Q3	$241K	Buy	+12,725	New	+$242K	0.09%	101
2017 Q4	–	Sell	-11,350	Closed	-$144K	–	221
2017 Q3	$144K	Buy	+11,350	New	+$144K	0.06%	191